The loss of phosphatase and tensin homologue (PTEN) deleted on chromosome 10 is prevalent in the majority of advanced prostate cancers leading to constitutive activation of the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway [8]. The gene discussed is AKT1; the disease is prostate cancer.